| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |